Net profit of Bafna Pharmaceuticals reported to Rs 1.81 crore in the quarter ended June 2020 as against net loss of Rs 2.13 crore during the previous quarter ended June 2019. Sales rose 143.80% to Rs 16.70 crore in the quarter ended June 2020 as against Rs 6.85 crore during the previous quarter ended June 2019.

Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 September 2020.

Powered by Capital Market - Live News

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 31 July 2020.

Powered by Capital Market - Live News

Net loss of Bafna Pharmaceuticals reported to Rs 0.16 crore in the quarter ended March 2020 as against net profit of Rs 0.06 crore during the previous quarter ended March 2019. Sales rose 0.46% to Rs 13.13 crore in the quarter ended March 2020 as against Rs 13.07 crore during the previous quarter ended March 2019.

For the full year,net loss reported to Rs 25.20 crore in the year ended March 2020 as against net loss of Rs 19.73 crore during the previous year ended March 2019. Sales declined 2.05% to Rs 42.47 crore in the year ended March 2020 as against Rs 43.36 crore during the previous year ended March 2019.

Powered by Capital Market - Live News